Top compounds associated with response to SRF


Feature Type Standardized
Nominal ANOVA
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.072 0.02
mRNA MLN2238 CTRPv2 pan-cancer AAC 0.082 0.02
mRNA BRD-K24690302 CTRPv2 pan-cancer AAC -0.087 0.02
mRNA AC55649 CTRPv2 pan-cancer AAC 0.089 0.02
mRNA SCH-79797 CTRPv2 pan-cancer AAC 0.082 0.02
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC -0.088 0.02
mRNA ELCPK CTRPv2 pan-cancer AAC 0.12 0.02
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC -0.085 0.02
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.082 0.02
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.082 0.03
Download CSV